Gambaran Umum
Bio-Rad Laboratories, Inc., based in the United States, is a prominent entity in the global life sciences and clinical diagnostics industry. Founded in 1952, the company specializes in producing and distributing a myriad of products, including specialized analytical instruments, software, and chemicals used for research and diagnostic purposes. Key projects by Bio-Rad focus on innovative solutions in genomics and proteomics, notably through advanced PCR (Polymerase Chain Reaction) techniques and quality control systems for laboratory testing. By fostering continuous development in biotechnology methodologies, Bio-Rad empowers clinical diagnostics and research laboratories to enhance precision and efficiency across diverse biological experiments and health-related tests. This strategic emphasis supports its robust standing in the scientific and healthcare sectors, driving forward both technological advancement and clinical outcomes.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah 2,554.20 MM.
- Nilai operating income untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah 253.50 MM.
- Nilai net income untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah 319.20 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 2,554.20 | 253.50 | 319.20 |
2025-03-31 | 2,541.10 | 274.20 | -2,164.10 |
2024-12-31 | 2,566.50 | 269.00 | -1,844.20 |
2024-09-30 | 2,580.15 | 311.09 | -778.70 |
2024-06-30 | 2,562.55 | 337.67 | -1,325.61 |
2024-03-31 | 2,605.16 | 327.59 | -322.36 |
2023-12-31 | 2,671.20 | 337.80 | -637.30 |
2023-09-30 | 2,720.37 | 365.95 | -159.30 |
2023-06-30 | 2,769.04 | 369.35 | -428.36 |
2023-03-31 | 2,779.03 | 402.32 | -191.23 |
2022-12-31 | 2,802.20 | 482.60 | -3,627.50 |
2022-09-30 | 2,804.73 | 548.93 | -6,020.57 |
2022-06-30 | 2,870.98 | 610.19 | -1,929.73 |
2022-03-31 | 2,895.81 | 611.08 | -90.50 |
2021-12-31 | 2,922.55 | 564.74 | 4,254.26 |
2021-09-30 | 2,979.61 | 557.19 | 6,658.66 |
2021-06-30 | 2,879.83 | 509.89 | 4,045.45 |
2021-03-31 | 2,700.78 | 437.55 | 4,097.77 |
2020-12-31 | 2,545.63 | 421.33 | 3,814.23 |
2020-09-30 | 2,380.22 | 324.82 | 3,520.65 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -65.36 | -65.36 |
2024-09-30 | -27.41 | -27.41 |
2024-06-30 | -46.19 | -46.20 |
2024-03-31 | -11.14 | -11.15 |
2023-12-31 | -21.82 | -21.82 |
2023-09-30 | -5.41 | -5.41 |
2023-06-30 | -14.48 | -14.47 |
2023-03-31 | -6.44 | -6.43 |
2022-12-31 | -121.79 | -121.79 |
2022-09-30 | -201.73 | -201.72 |
2022-06-30 | -64.61 | -64.61 |
2022-03-31 | -3.03 | -3.04 |
2021-12-31 | 142.61 | 140.83 |
2021-09-30 | 223.38 | 220.48 |
2021-06-30 | 135.82 | 134.05 |
2021-03-31 | 137.71 | 135.87 |
2020-12-31 | 128.13 | 126.47 |
2020-09-30 | 118.18 | 116.69 |
2020-06-30 | 65.29 | 64.50 |
2020-03-31 | 52.90 | 52.30 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah 534.20 MM.
- Nilai cash from investing activities untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah -198.70 MM.
- Nilai kas dari aktivitas pendanaan untuk Bio-Rad Laboratories, Inc. per 2025 Jun 30 adalah -356.20 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 534.20 | -198.70 | -356.20 |
2025-03-31 | 515.30 | -114.20 | -316.50 |
2024-12-31 | 455.20 | -160.20 | -218.80 |
2024-09-30 | 411.96 | -57.45 | -393.16 |
2024-06-30 | 346.12 | -11.31 | -323.77 |
2024-03-31 | 346.58 | 47.57 | -429.91 |
2023-12-31 | 374.90 | 20.20 | -425.60 |
2023-09-30 | 373.51 | -110.54 | -311.65 |
2023-06-30 | 286.82 | -189.46 | -293.82 |
2023-03-31 | 242.03 | -361.93 | -212.41 |
2022-12-31 | 194.40 | -1,207.60 | 973.60 |
2022-09-30 | 285.69 | -1,716.47 | 1,064.83 |
2022-06-30 | 505.03 | -1,709.40 | 1,058.02 |
2022-03-31 | 606.38 | -1,665.19 | 1,182.21 |
2021-12-31 | 669.50 | -797.38 | -55.43 |
2021-09-30 | 783.33 | -280.06 | -481.95 |
2021-06-30 | 688.63 | -107.86 | -465.93 |
2021-03-31 | 626.13 | -96.16 | -471.77 |
2020-12-31 | 585.00 | -69.89 | -523.04 |
2020-09-30 | 450.40 | -71.34 | -105.94 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.80.
- p/tbv untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.90.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.80 | 0.90 | |
2025-03-31 | 0.98 | 1.10 | |
2024-12-31 | 1.22 | 1.35 | |
2024-09-30 | -5.71 | 1.12 | 1.25 |
2024-06-30 | 0.00 | 0.00 | 0.00 |
2024-03-31 | 0.00 | 0.00 | 0.00 |
2023-12-31 | 0.00 | 0.00 | 0.00 |
2023-09-30 | -24.10 | 1.22 | 1.34 |
2023-06-30 | 0.00 | 0.00 | 0.00 |
2023-03-31 | 0.00 | 0.00 | |
2022-12-31 | 0.00 | 0.00 | |
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | ||
2022-03-31 | 0.00 | 0.00 | 0.00 |
2021-12-31 | 0.00 | 0.00 | 0.00 |
2021-09-30 | 0.00 | 0.00 | 0.00 |
2021-06-30 | |||
2021-03-31 | 0.00 | 0.00 | 0.00 |
2020-12-31 | 0.00 | 0.00 | 0.00 |
2020-09-30 | 0.00 | 0.00 | 0.00 |
2020-06-30 | 0.00 | 0.00 | 0.00 |
2020-03-31 | 0.00 | 0.00 | 0.00 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.46.
- EBIT (3 tahun) / EV untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.28.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.46 | -0.28 |
2025-03-31 | -0.33 | -0.14 |
2024-12-31 | -0.10 | -0.22 |
2024-09-30 | -0.21 | -0.39 |
2024-06-30 | -0.58 | -0.40 |
2024-03-31 | -1.07 | -0.05 |
2023-12-31 | -0.25 | 0.24 |
2023-09-30 | -0.05 | 0.06 |
2023-06-30 | -0.34 | 1.07 |
2023-03-31 | -6.16 | 0.16 |
2022-12-31 | -11.53 | 2.57 |
2022-09-30 | -4.35 | 5.82 |
2022-06-30 | -0.58 | 6.33 |
2022-03-31 | -11.83 | -9.26 |
2021-12-31 | -10.09 | -6.18 |
2021-09-30 | -7.24 | -4.75 |
2021-06-30 | ||
2021-03-31 | -8.03 | -4.09 |
2020-12-31 | -7.57 | -3.95 |
2020-09-30 | -10.96 | -5.37 |
2020-06-30 | -4.14 | -2.75 |
2020-03-31 | -12.32 | -7.57 |
Efektivitas Manajemen
- roa untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.22.
- roe untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.32.
- roic untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.27.
- croic untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.01.
- ocroic untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.06.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.22 | -0.32 | -0.27 | 0.01 | 0.06 |
2025-03-31 | -0.15 | -0.20 | -0.23 | 0.01 | 0.06 |
2024-12-31 | -0.06 | -0.09 | -0.09 | -0.01 | 0.05 |
2024-09-30 | -0.11 | -0.16 | -0.16 | 0.00 | 0.04 |
2024-06-30 | -0.02 | -0.03 | -0.03 | -0.00 | 0.03 |
2024-03-31 | -0.05 | -0.07 | -0.06 | -0.00 | 0.04 |
2023-12-31 | -0.01 | -0.02 | -0.02 | -0.01 | 0.04 |
2023-09-30 | -0.03 | -0.05 | -0.04 | -0.02 | 0.03 |
2023-06-30 | -0.02 | -0.02 | -0.04 | -0.02 | 0.03 |
2023-03-31 | -0.25 | -0.36 | -0.02 | -0.03 | 0.02 |
2022-12-31 | -0.30 | -0.39 | -0.62 | -0.04 | 0.03 |
2022-09-30 | -0.10 | -0.13 | -0.62 | -0.04 | 0.03 |
2022-06-30 | -0.01 | -0.01 | -0.19 | -0.01 | 0.05 |
2022-03-31 | 0.30 | 0.40 | -0.01 | 0.01 | 0.06 |
2021-12-31 | 0.51 | 0.67 | 0.31 | -0.01 | 0.05 |
2021-09-30 | 0.34 | 0.46 | 0.43 | 0.00 | 0.06 |
2021-06-30 | 0.40 | 0.55 | 0.34 | 0.01 | 0.06 |
2021-03-31 | 0.47 | 0.65 | 0.38 | 0.01 | 0.06 |
2020-12-31 | 0.48 | 0.66 | 0.38 | 0.00 | 0.06 |
2020-09-30 | 0.49 | 0.69 | 0.37 | 0.03 | 0.05 |
2020-06-30 | 0.25 | 0.35 | 0.26 | 0.00 | 0.05 |
2020-03-31 | 0.23 | 0.32 | 0.23 | 0.02 | 0.07 |
Gross Margins
- marjin kotor untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.54.
- marjin bersih untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah -0.85.
- marjin operasi untuk Bio-Rad Laboratories, Inc. pada 2025 Jun 30 adalah 0.11.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.54 | -0.85 | 0.11 |
2025-03-31 | 0.54 | -0.72 | 0.12 |
2024-12-31 | 0.54 | -0.30 | 0.13 |
2024-09-30 | 0.54 | -0.52 | 0.13 |
2024-06-30 | 0.54 | -0.12 | 0.13 |
2024-03-31 | 0.54 | -0.24 | 0.13 |
2023-12-31 | 0.54 | -0.06 | 0.13 |
2023-09-30 | 0.54 | -0.15 | 0.14 |
2023-06-30 | 0.55 | -0.15 | 0.14 |
2023-03-31 | 0.56 | -0.07 | 0.15 |
2022-12-31 | 0.56 | -2.15 | 0.16 |
2022-09-30 | 0.57 | -2.15 | 0.16 |
2022-06-30 | 0.57 | -0.68 | 0.18 |
2022-03-31 | 0.57 | -0.03 | 0.18 |
2021-12-31 | 0.58 | 1.45 | 0.20 |
2021-09-30 | 0.57 | 2.23 | 0.21 |
2021-06-30 | 0.57 | 1.40 | 0.20 |
2021-03-31 | 0.57 | 1.52 | 0.19 |
2020-12-31 | 0.57 | 1.50 | 0.17 |
2020-09-30 | 0.55 | 1.48 | 0.14 |
2020-06-30 | 0.55 | 0.85 | 0.12 |
2020-03-31 | 0.55 | 0.68 | 0.12 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 12208 |
Grupong Pang-industriya
SIC 3826 - Laboratory Analytical Instruments |